letrozole an letrozole 2.5 mg film-coated tablet blister pack
juno pharmaceuticals pty ltd - letrozole -
femara 2.5mg film-coated tablet
novartis corporation (malaysia) sdn. bhd. - letrozole -
femara letrozole 2.5mg tablet blister pack
novartis pharmaceuticals australia pty ltd - letrozole, quantity: 2.5 mg - tablet, film coated - excipient ingredients: iron oxide yellow; lactose monohydrate; sodium starch glycollate; hypromellose; macrogol 8000; colloidal anhydrous silica; maize starch; magnesium stearate; microcrystalline cellulose; titanium dioxide; purified talc - for the treatment of postmenopausal women with hormone receptor positive breast cancer (see clinical trials). the safety and efficacy of neoadjuvant use of letrozole has not been established. letrozole is not indicated in hormone receptor negative disease.
femara tablet 2.5 mg
novartis (singapore) pte ltd - letrozole - tablet, film coated - 2.5 mg - letrozole 2.5 mg
femara 2,5 tablet
novartis south africa (pty) ltd - tablet - see ingredients - each tablet contains letrozole 2,5 mg
femara 2,5 mg film-coated tablet
impexeco - letrozole - film-coated tablet - 2,5 mg - letrozole 2.5 mg - letrozole
femara 2,5 mg film-coated tablet
pi pharma - letrozole - film-coated tablet - 2,5 mg - letrozole 2.5 mg - letrozole
femara 2.5mg tablets
novartis pharmaceuticals uk ltd - letrozole - oral tablet - 2.5mg
femara 2.5 mg tablet film-coated tablet
novartis - letrozole - film-coated tablet - 2.5 mg
femara 2.5 mg tablet film-coated tablet
novartis pharma ag, switzerland - letrozole - film-coated tablet - 2.5 mg